Web Results
The FDA recently gave its approval to several new drugs that are part of a new
class of diabetes drugs, the SGLT2 inhibitors. All have very troubling side effects.
More are awaiting approval. The first of these was Johnson & Johnson's drug
canagliflozin, which is marketed in the U.S. as Invokana.
What are Invokana and Farxiga? Invokana (canagliflozin) and Farxiga (
dapagliflozin) belong to the drug class sodium-glucose co-transporter-2 (SGLT2)
inhibitors. The FDA approved Invokana in March 2013 and Farxiga was
approved in January 2014. They are both indicated for blood glucose (sugar)
con
Compare Jardiance vs Invokana vs Farxiga cost, side effects, and dosage. These
are the new diabetes type-2 treatment drugs, approved by FDA. These oral
diabetes pills get rid of glucose from the bloodstream, by excreting it into the
urine. The manufacturers also claim that they cause weight loss,